Cargando…
A Concise Review of the Multimodality Imaging Features of Renal Cell Carcinoma
The evaluation of renal cell carcinoma (RCC) is routinely performed using the multimodality imaging approach, including ultrasonography, computed tomography (CT), magnetic resonance imaging (MRI), and positron emission tomography (PET). Ultrasonography is the most frequently used imaging modality fo...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7946646/ https://www.ncbi.nlm.nih.gov/pubmed/33728180 http://dx.doi.org/10.7759/cureus.13231 |
_version_ | 1783663095107813376 |
---|---|
author | Morshid, Ali Duran, Elif S Choi, Woongsoon J Duran, Cihan |
author_facet | Morshid, Ali Duran, Elif S Choi, Woongsoon J Duran, Cihan |
author_sort | Morshid, Ali |
collection | PubMed |
description | The evaluation of renal cell carcinoma (RCC) is routinely performed using the multimodality imaging approach, including ultrasonography, computed tomography (CT), magnetic resonance imaging (MRI), and positron emission tomography (PET). Ultrasonography is the most frequently used imaging modality for the initial diagnosis of renal masses. The modality of choice for the characterization of the renal mass is multiphasic CT. Recent advances in CT technology have led to its widespread use as a powerful tool for preoperative planning, reducing the need for catheter angiography for the evaluation of vascular invasion. CT is also the standard imaging modality for staging and follow-up. MRI serves as a problem-solving tool in selected cases of undefined renal lesions. Newer MRI techniques, such as arterial spin labeling and diffusion-weighted imaging, have the potential to characterize renal lesions without contrast media, but these techniques warrant further investigation. PET may be a useful tool for evaluating patients with suspected metastatic disease, but it has modest sensitivity in the diagnosis and staging of RCC. The newer radiotracers may increase the accuracy of PET for RCC diagnosis and staging. In summary, the main imaging modality used for the characterization, staging, and surveillance of RCC is multiphasic CT. Other imaging modalities, such as MRI and PET, are used for selected indications. |
format | Online Article Text |
id | pubmed-7946646 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Cureus |
record_format | MEDLINE/PubMed |
spelling | pubmed-79466462021-03-15 A Concise Review of the Multimodality Imaging Features of Renal Cell Carcinoma Morshid, Ali Duran, Elif S Choi, Woongsoon J Duran, Cihan Cureus Radiology The evaluation of renal cell carcinoma (RCC) is routinely performed using the multimodality imaging approach, including ultrasonography, computed tomography (CT), magnetic resonance imaging (MRI), and positron emission tomography (PET). Ultrasonography is the most frequently used imaging modality for the initial diagnosis of renal masses. The modality of choice for the characterization of the renal mass is multiphasic CT. Recent advances in CT technology have led to its widespread use as a powerful tool for preoperative planning, reducing the need for catheter angiography for the evaluation of vascular invasion. CT is also the standard imaging modality for staging and follow-up. MRI serves as a problem-solving tool in selected cases of undefined renal lesions. Newer MRI techniques, such as arterial spin labeling and diffusion-weighted imaging, have the potential to characterize renal lesions without contrast media, but these techniques warrant further investigation. PET may be a useful tool for evaluating patients with suspected metastatic disease, but it has modest sensitivity in the diagnosis and staging of RCC. The newer radiotracers may increase the accuracy of PET for RCC diagnosis and staging. In summary, the main imaging modality used for the characterization, staging, and surveillance of RCC is multiphasic CT. Other imaging modalities, such as MRI and PET, are used for selected indications. Cureus 2021-02-08 /pmc/articles/PMC7946646/ /pubmed/33728180 http://dx.doi.org/10.7759/cureus.13231 Text en Copyright © 2021, Morshid et al. http://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Radiology Morshid, Ali Duran, Elif S Choi, Woongsoon J Duran, Cihan A Concise Review of the Multimodality Imaging Features of Renal Cell Carcinoma |
title | A Concise Review of the Multimodality Imaging Features of Renal Cell Carcinoma |
title_full | A Concise Review of the Multimodality Imaging Features of Renal Cell Carcinoma |
title_fullStr | A Concise Review of the Multimodality Imaging Features of Renal Cell Carcinoma |
title_full_unstemmed | A Concise Review of the Multimodality Imaging Features of Renal Cell Carcinoma |
title_short | A Concise Review of the Multimodality Imaging Features of Renal Cell Carcinoma |
title_sort | concise review of the multimodality imaging features of renal cell carcinoma |
topic | Radiology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7946646/ https://www.ncbi.nlm.nih.gov/pubmed/33728180 http://dx.doi.org/10.7759/cureus.13231 |
work_keys_str_mv | AT morshidali aconcisereviewofthemultimodalityimagingfeaturesofrenalcellcarcinoma AT duranelifs aconcisereviewofthemultimodalityimagingfeaturesofrenalcellcarcinoma AT choiwoongsoonj aconcisereviewofthemultimodalityimagingfeaturesofrenalcellcarcinoma AT durancihan aconcisereviewofthemultimodalityimagingfeaturesofrenalcellcarcinoma AT morshidali concisereviewofthemultimodalityimagingfeaturesofrenalcellcarcinoma AT duranelifs concisereviewofthemultimodalityimagingfeaturesofrenalcellcarcinoma AT choiwoongsoonj concisereviewofthemultimodalityimagingfeaturesofrenalcellcarcinoma AT durancihan concisereviewofthemultimodalityimagingfeaturesofrenalcellcarcinoma |